GSA Capital Partners’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56K | Sell |
33,818
-2,809
| -8% | -$4.65K | ﹤0.01% | 1657 |
|
|
2025
Q1 | $49K | Buy |
+36,627
| New | +$49K | ﹤0.01% | 1549 |
|
|
2022
Q1 | – | Sell |
-88,544
| Closed | -$1.12M | – | 1750 |
|
|
2021
Q4 | $1.12M | Buy |
88,544
+73,491
| +488% | +$927K | 0.14% | 159 |
|
|
2021
Q3 | $1.38M | Buy |
15,053
+1,758
| +13% | +$161K | 0.14% | 163 |
|
|
2021
Q2 | $705K | Buy |
+13,295
| New | +$705K | 0.08% | 415 |
|